Lab Glassware Division 中文(Chinese)

HPLC Method for Determination of Molnupiravir, a Promising Treatment for COVID-19

Method: HPLC
Matrix: Medicine
Application No.: 101952
Componds: Molnupiravir
Columns: Diamonsil® Plus C18 5μm 250 x 4.6 mm
Cat No.: 99403
Sample Pretreatment: Molnupiravir solid standard was dissolved in methanol to make standard stock solution of 1 mg/mL. Working solution of 50 µg/mL was obtained by dilution of the stock solution with acetonitrile/water (1/1, v/v). All standard solutions should be stored at 4 ℃.
Conditions: Mobile Phase:
A: 0.1% phosphoric acid in water;
B: acetonitrile
Flow Rate: 1.0 mL/min
Wavelength: 235 nm
Injection: 10 µL
Temperature: 30 ℃
Publisher: Dikma Technologies Inc.
Keyword: Molnupiravir, COVID-19, HPLC, Diamonsil Plus C18
Abstract: HPLC Method provide simple and rapid determination of molnupiravir and can be easily applied to drug development and clinical trial studies of this promising treatment.

Compound

Concentration (µg/mL)

Retention Time (min)

USP Tailing factor

Molnupiravir

50

3.530

1.08